![]() | |
Company type | Private |
---|---|
Industry | Pharmaceutical |
Founded | 1995 |
Founder | Muhammad Jawed Akhai |
Headquarters | Karachi, Pakistan |
Area served | Asia, Middle East, Europe, Africa |
Products | ADVIT-D, BUSCOPAN PLUS, CONCOR, GLUCOPHAGE, INFEXIN CAPS, KLARIBACT, MERCIP, NEUROBION, POLYBION, ROZANTO, SANGOBION, TIXOMER, VONOSPIRE, WINTOGENO |
Revenue | ![]() |
Number of employees | 1,000+ [2] |
Subsidiaries | Martin Dow Limited Martin Dow Marker Ltd. Martin Dow Specialities (Pvt.) Ltd. Martin Dow Pharmaceuticals (France) |
Website | martindow |
Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi. It was founded in 1995 [3] [4] and has six manufacturing facilities in Pakistan [5] and one in France. [6]
Martin Dow was founded in 1995 and began operations in 2000 with a small manufacturing facility in Lahore. [7]
In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan. [8]
In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum. [9] In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company. [10]
In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd. [11] [12] [13]
In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France. [14] [15] In March 2017, the French President Francois Hollande inaugurated Martin Dow Pharma's Meymac Plant in France. [16] [17] The plant of V2Pharm in Gien, France was also taken over by Martin Dow. [18]
In 2020, Martin Dow was awarded for excellent performance in fire safety and protection by the Sindh local government minister. [19]
In 2016, the National Accountability Bureau (NAB) arrested two directors of Martin Dow because it wrongfully derived financial benefits on the basis of illegal price increase. [20] [21] [22]
Martin Dow was established in 1995 initially as a pharmaceutical marketing company in Karachi (Pakistan)
With the acquisition of Merck Pakistan, Martin Dow will have six manufacturing facilities in the country.
A Pakistani Pharmaceutical company, Martin Dow has acquired a pharmaceutical manufacturing facility in Meymac, France. The facility was earlier owned by the renowned pharmaceutical firm Bristol-Myers Squibb.